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Summary 
 
 According to research commissioned by the Irish Cancer Society, there are approximately 134,000 e-
cigarette users in Ireland.   
 Research into the long-term effects of their using e-cigarettes is not yet available. 
 The Irish Cancer Society cannot recommend the use of e-cigarettes without guarantees on their long-
term safety. 
 In the absence of proven safety and efficacy, the Society wants the Department of Health to regulate 
e-cigarettes as medicinal product. 
 The Irish Cancer Society is committed to a reduction in the rate of smoking in Ireland and has been a 
tireless advocate of the Government’s goal of a Tobacco Free Ireland by 2025. We recommend that 
smokers seeking to quit do so by giving up immediately and permanently. 
 The Irish Cancer Society wants to ensure marketing of e-cigarettes ‘denormalises’ smoking rather 
than renormalise it.  
 The Irish Cancer Society believes the workplace smoking ban should not be undermined and therefore 
supports employers who keep their workplaces free of e-cigarette use. 
 
 
 
Background 
Electronic cigarettes, also known as ‘vaporisers’ or Electronic Nicotine Delivery Systems (ENDS), are mechanical 
devices that are marketed as a less harmful alternative to cigarettes. While conventional cigarettes contain 
thousands of toxic chemicals, an e-cigarette is designed to deliver nicotine, a highly addictive substance that is 
poisonous in high concentrations.  
 
There are three types of e-cigarette currently on the market in Ireland: 
 Disposable, non-rechargeable devices that provide a certain number of ‘puffs’ 
 Rechargeable devices using pre-filled replaceable liquid cartridges 
 Rechargeable devices containing a tank or reservoir that is filled with liquid manually 
 
E-cigarettes allow the inhalation of vaporised nicotine dissolved in propylene glycol or glycerine and are 
designed around a battery, an atomizer and a cartridge of liquid. The level of nicotine in an e-cigarette has 
been found to vary widely.
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 When the user sucks on an e-cigarette, a sensor detects air flow and heats the 
liquid in the cartridge so that it evaporates.  The majority of devices have a tip that lights up when used.  
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E-Cigarettes in Ireland 
According to research commissioned by the Irish Cancer Society, there are approximately 134,000 e-cigarette 
users in Ireland.  The vast majority of these are either current tobacco smokers or former tobacco smokers and 
there is little evidence that the devices are used by people who have never smoked tobacco.
2
  
 
 
 
The primary motivation for e-cigarette users is to stop smoking (62%) but just over half (55%) were successful 
in achieving that aim. The second most popular motivation was to cut down the number of cigarettes they 
smoke and a similar number (59%) believed the devices helped them to do so. The research has also shown 
that upwards of one-third of current e-cigarette users continue to smoke tobacco cigarettes simultaneously.  
 
Almost 8 in 10 Irish people acknowledge that not enough is known about the health effects of e-cigarettes but 
despite this 45% agree that the devices are not as harmful as tobacco cigarettes. 44% of Irish people say they 
would have ‘no problem’ with people using e-cigarettes in places where smoking is banned but it should be 
noted that a resistance to such a proposal is highest among ex-smokers as well as non-smokers. 
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Safety 
Compared to smoking tobacco, e-cigarettes are deemed to be safer; however, there is no research into the 
long-term effects of their usage. The Irish Cancer Society cannot recommend the use of e-cigarettes without 
guarantees of their long-term safety.  
 
In the absence of regulation, the quality and safety of e-cigarettes varies by brand. There have been recent 
media reports in Ireland and the UK of devices exploding
4
 and of an increase in incidences of nicotine 
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poisoning caused by e-cigarettes.
5
 In Ireland, there were as many incidents of nicotine poisoning in the first 
three months of 2014 as in the whole of 2013. 11 of these cases involved children less than six years of age.
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All were allegedly caused by the ingestion of liquid for e-cigarettes. 
 
Nicotine affects the peripheral and central nervous systems, and has been shown to increase heart rate and 
blood pressure while constricting cutaneous and coronary blood vessels.
7
 Some studies suggest that nicotine 
may promote tumour growth in human cells.
8
 The WHO have also cautioned children and adolescents, 
pregnant women and women of reproductive age against using e-cigarettes because of the potential for foetal 
and adolescent nicotine exposure to have long-term consequences for brain development.
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Do they help smokers to quit?  
81 per cent of smokers in Ireland plan to quit smoking.
10
 The Irish Cancer Society recommends that smokers 
give up immediately and permanently. Professional smoking cessation services, along with the use of 
traditional Nicotine Replacement Therapies (NRT) increase the chances of success in quitting up to four 
times.
11
 Yet, there is evidence to suggest that smokers are increasingly relying on e-cigarettes to help them 
give up,
12
 and that a majority of people have found them more effective than traditional NRT.
13
  
 
The World Health Organisation has stated that “the electronic cigarette is not a proven nicotine replacement 
therapy”
14
 and much of the research into e-cigarettes has been unable to assess whether they help people to 
quit.  
 
Quitting all nicotine remains the safest and most reliable way of giving up smoking. Further research into the 
efficacy of e-cigarettes as an aid to quit is required before the Irish Cancer Society can recommend these 
devices. There is evidence that smokers relying on e-cigarettes to quit are using them alongside tobacco and 
becoming ‘dual-users’. 
15
 The use of even a small number of cigarettes is detrimental to a person’s health and 
increases their chances of developing lung cancer.  
 
E-cigarettes could be a tool for harm reduction in the future, but for this to happen, studies of the long-term 
effects must be concluded and the regulation of all e-cigarettes as medicinal products is a must.  The revised 
EU Tobacco Products Directive means Ireland must regulate any e-cigarette with a nicotine level above 
20mg/ml as a medicinal product.  The Department of Health should go further. Such regulation should inform 
tobacco smokers in making decisions on the best way for them to quit.  
 
 
Legislation 
There are currently no regulations governing the sale or safety of e-cigarettes.  The devices are not considered 
tobacco or medicinal products and are regulated in the same way as other consumer products such as watches 
and toys.  For this reason, no two brands of e-cigarette are the same and the Irish Cancer Society has serious 
concerns with regard to their safety and efficacy.  
 
In 2014, agreement was reached to include e-cigarettes in the European Union’s Revised Tobacco Products 
Directive (TPD).
16
  The new rules which must come into effect in Ireland by 2016 include:  
 banning the sale of e-cigarettes to under-18s 
 improved safety and quality requirements for products 
 new packaging and labelling requirements 
 E-cigarette manufacturers will be required to notify Member States before placing new products on 
the market and report annually on the sales volumes of the products, types of users and their 
preferences and trends. 
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 specific rules on advertising 
 
However the Irish Cancer Society believes that the onus is on the Irish authorities to build on the provisions of 
the Tobacco Products Directive and introduce further regulation on: 
 classifying all e-cigarettes as medicinal products 
 banning of certain flavours of e-cigarette liquid 
 marketing and advertising 
 the ‘re-normalisation’ of smoking 
 
 
Legislation around Europe17 
Country Status 
 Austria Classified as a medicinal device; liquid containing nicotine regulated as a pharmaceutical 
 Belgium Medical licence required for the sale of refills or cartridges of liquid containing nicotine.  
 Denmark Nicotine-containing devices regulated as a pharmaceutical product 
 France Presented as cessation treatment – listed as a pharmaceutical 
If not, >10mg of nicotine – listed as a pharmaceutical;  
<10mg of nicotine – general safety rules 
 Sweden Liquid containing nicotine regulated as a pharmaceutical 
 UK By 2016, all e-cigarettes to be regulated as medicines 
 IRELAND Consumer regulation only 
 
 
Marketing 
The vast majority of e-cigarette users are smokers who see them as an alternative to tobacco.  Nevertheless, 
there is a growing market for e-cigarettes and 96% of the adult population are aware of the device.
18
 The Irish 
Cancer Society welcomes government moves to ban the sale of e-cigarettes to people under the age of 18.
19
  
 
The Society and the Irish Heart Foundation commissioned research on branding and packaging as part of our 
campaign for the introduction of standardised packaging of tobacco.  It is clear from this research that 
branding and marketing is integral to teens’ lives and the focus groups indicated that design and marketing 
influenced everything from perception of quality to the likely users of the brand.
20
 It is for these reasons that 
we believe there is an urgent need to regulate the marketing of e-cigarettes.  
 
E-cigarettes are not classified as a tobacco product in Ireland and therefore are not subjected to the same 
restrictions on advertising and marketing.  The Advertising Standards Authority of Ireland (ASAI) has no specific 
provisions in their code regarding e-cigarettes, however the Department of Health are providing input to a 
revised Code that will include e-cigarettes.
21
  The Society welcomes this and envisages that it will reflect the 
revised EU Tobacco Products Directive (TPD) which includes a ban on advertising in the press, on radio and 
television and at events involving several EU countries.
22
 However, TPD provides only a base for countries to 
regulate domestic marketing and advertising. TPD won’t regulate the many exotic flavours available for e-
cigarettes, for example.  Neither will it regulate the many innovations happening in branding and marketing. 
 
 
Numerous flavours from beer to banana and bubblegum and variations such as e-shisha are promoted in 
colourful and innovative packaging. Blu Ecigs, for example, introduced ‘smart packs’ that alert users when they 
come into fifty feet of other users – both packs start vibrating and flashing a blue light.  The packs can be set to 
transmit Facebook and Twitter profiles in the event that users do not wish to approach others in real life 
settings, but would rather make virtual friends. 
- ‘E-cigarette uptake and marketing’, A Report for Public Health England 
23
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The Irish Cancer Society wants to ensure marketing of e-cigarettes continues to ‘denormalise’ smoking rather 
than renormalise it.  
 
 
The Tobacco Industry  
The growth in the e-cigarette market has seen independent developers and suppliers being acquired by 
tobacco companies in pursuit of profit.  All major tobacco multinationals are now active in the e-cigarette 
industry and this is a cause of concern to the Irish Cancer Society.   
 
Lorillard – the third largest tobacco company in the United States – paid €113 million for the e-cigarette 
company Blu in 2012 and paid €38 million to the Scottish-based Skycig in 2013. 
24
 Philip Morris (PMI), the 
brand behind Marlboro bought the e-cigarette start-up Green Smoke Inc. for €83 million in February 2014.
25
  
British American Tobacco (BAT) – which owns PJ Carroll in Ireland – merged its wholly-owned subsidiary 
Nicoventures with their own Research and Development Department to create ‘Vype’ e-cigarette.
26
 
 
 
“This is a huge growth opportunity.  We want to lead.” 
- Dr David O’Reilly, British American Tobacco
27
 
 
 
Academics suggest the Big Tobacco’s involvement in e-cigarettes will merely serve to ‘re-normalize’ an 
industry that is determined to be seen as a responsible business with a legitimate product.
28
 
 
The Irish Cancer Society maintains that the WHO Framework Convention on Tobacco Control (FCTC) must be 
upheld.
29
  The Convention recognises the ‘fundamental and irreconcilable conflict between the tobacco 
industry’s interests and public health policy interests’. Article 5.3 of the Convention also states that 
Government must protect health policy from the vested interests of the tobacco industry.  
 
Ireland is a signatory to FCTC and it is imperative that State bodies continue to maintain a distance from the 
vested interests of the tobacco industry.  
 
 
E-cigarettes and the Workplace Smoking Ban 
Ireland recently marked ten years since the introduction of the Workplace Smoking Ban, which was designed 
to reduce the risk to employees of second-hand smoke and to encourage more smokers to quit.  The ban has 
been an unqualified success with the number of smokers falling by a quarter in ten years. 
30
 
 
While there is little doubt second-hand vapour from an e-cigarette is less harmful than second-hand tobacco 
smoke, vapour does contain toxicants. 
31
 Further research is required into the impact of exposure to e-
cigarette vapour.  
 
Allowing e-cigarettes to be used in places where tobacco is banned could delay or prevent quit attempts by 
those who would otherwise have quit. Wales has proposed the inclusion of e-cigarettes in the existing 
workplace smoking ban ‘to ensure their use does not undermine smoking prevention and cessation by 
reinforcing and normalising smoking’.
32
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In Ireland, it is not illegal to use e-cigarettes in the workplace, but the vacuum in the absence of regulation 
means that individual companies have already banned e-cigarettes including the HSE, Dublin Bus, Irish Rail and 
some shopping centres.
33
  
 
The Irish Cancer Society believes the workplace smoking ban should not be undermined.  
 
In deciding whether e-cigarettes undermine the workplace smoking ban, businesses and organisations should 
consider: 
 Do you have concerns about the relative safety and harm from e-cigarettes? 
 Are you considering a ban to continue projecting a ‘clean, healthy’ image of your business? 
 Does a ban need to cover ‘lookalike’ e-cigarettes or all vapour-emitting devices? 
 Is a ban practical for your business? 
34
 
 
 
The future of e-cigarettes 
Product innovation is seeing a boost in the sales of e-cigarettes, with companies vying for a share of the 
industry worth around €115 million globally per year.
35
 In Ireland, there are an estimated 134,000 current 
users of e-cigarettes with an increasing number of people trialling them to cut down or quit smoking.  
 
Companies are coming up with new ways of attracting smokers with e-cigarettes housing Bluetooth 
technology, devices linked to mobile phone apps and products that emit no vapour when exhaled in order to 
‘revolutionise vaping in public places’.
36
 
 
The EU Tobacco Products Directive – which will introduce regulations on e-cigarettes for the first time 
including a ban on selling to under-18s and restrict marketing – must be introduced in Ireland by the end of 
2016. The Department of Health here has stated its intention to introduce some regulations by the end of 
2014.  
 
The Irish Cancer Society welcomes the introduction of laws covering a thus far unregulated industry. However, 
in the absence of proven safety and efficacy, the Society wants the Department of Health to regulate e-
cigarettes as medicinal product.  
 
This is the only method by which e-cigarettes can be regarded as an aid to the quitting of smoking.  
 
For information and support on how to quit smoking, call the HSE Quit Team on  
Freefone 1800 201 203 or visit Quit.ie 
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